Vertex(VRTX) - 2025 Q2 - Quarterly Results

Vertex Reports Second Quarter 2025 Financial Results — Total revenue of $2.96 billion, a 12% increase compared to Q2 2024; reiterated full year 2025 financial guidance, including revenue guidance of $11.85 to $12 billion — — Continued strong execution of CASGEVY , ALYFTREK and JOURNAVX launches — ® ® ® Second Quarter 2025 Results Total revenue increased 12% to $2.96 billion compared to the second quarter of 2024, primarily driven by the continued performance of cystic fibrosis (CF) therapies and early contr ...